News & Articles

The EBV panel can be used to rule out other acute infections, such as missed HIV infections

Review the experimental workflow from sample processing to sequencing and data analysis with this on-demand webinar

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Next-generation polymer dyes can improve accuracy and brightness with reduced nonspecific staining

The exclusive accessory can be configured for the magnetic field to be applied either in-plane with the sample or out-of-plane.

Watch this on-demand webinar for expert insight into spectral cell analysis and how it may be used to generate parametric data

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

A response to the unprecedented global demand for key scientific resources

New system provides end-to-end solution for researchers to validate specificity of CRISPR and other genome editing projects

The new system supports remote operability for laboratory processes

Dr. John Wilson explains how ProtiFi set out to develop solutions to all the problems preventing omics from delivering real clinical impact

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase

The White FOx aims to bring maximum flexibility, control, and insight to diagnostic development, life science and (bio)pharmaceutical research